The Future of Precision Medicine is Radiopharmaceuticals

• by Mona-Elisabeth Rootwelt-Revheim

• January 12, 2026

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

• by Anuradha Jayaram, Memuna Rashid, Alison H. M. Reid, Francesco Orlando, Suparna Thakali, Leila Zakka, Miriam Goncalves, Jacqueline O’Dwyer, Constantine Alifrangis, Rob Jones, Elias Pintus, Sarah Needleman, Diletta Bianchini, Anna Wingate, Kenrick Ng, Mark Linch, Ursula McGovern, John Staffurth, Simon J. Crabb, Susannah Brock, Alison Birtle, Osvaldas Vainauskas, Gianmarco Leone, Millenn Chiwewe, Allan Hackshaw, Andre Lopes, Daniel Wetterskog, Francesca Demichelis, Gerhardt Attard

• May 15, 2026

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges

• by Shuyu Ren, Fangfang Pan, Jie Jin

• May 14, 2026

Digital Health in Pediatric Neurology: From Episodic to Continuous Care

Digital health has emerged as a transformative force in 21st-century medicine, reshaping the boundaries of healthcare delivery.

• by

• May 12, 2026

• 4 min